Canada markets close in 2 hours 43 minutes
  • S&P/TSX

    20,193.08
    -84.33 (-0.42%)
     
  • S&P 500

    3,951.93
    -5.70 (-0.14%)
     
  • DOW

    33,705.61
    -146.92 (-0.43%)
     
  • CAD/USD

    0.7383
    +0.0018 (+0.24%)
     
  • CRUDE OIL

    80.29
    +2.09 (+2.67%)
     
  • BTC-CAD

    22,744.61
    +420.06 (+1.88%)
     
  • CMC Crypto 200

    398.52
    -2.18 (-0.54%)
     
  • GOLD FUTURES

    1,765.30
    +1.60 (+0.09%)
     
  • RUSSELL 2000

    1,825.33
    -11.22 (-0.61%)
     
  • 10-Yr Bond

    3.7680
    +0.0200 (+0.53%)
     
  • NASDAQ

    11,018.86
    +35.08 (+0.32%)
     
  • VOLATILITY

    22.55
    +0.66 (+3.02%)
     
  • FTSE

    7,573.05
    +61.05 (+0.81%)
     
  • NIKKEI 225

    27,968.99
    -58.85 (-0.21%)
     
  • CAD/EUR

    0.7151
    +0.0025 (+0.35%)
     

Labcorp to Speak at the Baird 2022 Global Healthcare Conference

BURLINGTON, N.C., September 06, 2022--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET.

A live webcast of the fireside chat will be available via the Labcorp Investor Relations website and archived for replay.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.

# # #

View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005458/en/

Contacts

Labcorp Contacts:
Investors: Chas Cook — 336-436-5076
Investor@Labcorp.com

Media: Christopher Allman-Bradshaw — 336-436-8263
Media@Labcorp.com